Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4276932
Max Phase: Preclinical
Molecular Formula: C46H68N6O5
Molecular Weight: 785.09
Molecule Type: Small molecule
Associated Items:
ID: ALA4276932
Max Phase: Preclinical
Molecular Formula: C46H68N6O5
Molecular Weight: 785.09
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)O)c1cccc2ccccc12
Standard InChI: InChI=1S/C46H68N6O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-31-42(53)50-39(30-23-32-49-46(47)48)44(55)52-40(38-29-22-27-36-26-20-21-28-37(36)38)34-43(54)51-41(45(56)57)33-35-24-17-16-18-25-35/h16-18,20-22,24-29,39-41H,2-15,19,23,30-34H2,1H3,(H,50,53)(H,51,54)(H,52,55)(H,56,57)(H4,47,48,49)/t39-,40-,41-/m0/s1
Standard InChI Key: HWDNNXRSMLPGFR-YKXUKSTASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 785.09 | Molecular Weight (Monoisotopic): 784.5251 | AlogP: 8.21 | #Rotatable Bonds: 30 |
Polar Surface Area: 186.50 | Molecular Species: ZWITTERION | HBA: 5 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 11 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 3.83 | CX Basic pKa: 11.92 | CX LogP: 7.08 | CX LogD: 7.08 |
Aromatic Rings: 3 | Heavy Atoms: 57 | QED Weighted: 0.02 | Np Likeness Score: -0.05 |
1. Naik H, Gauthier T, Singh S, Jois S.. (2018) Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2 + cancer., 28 (22): [PMID:30314880] [10.1016/j.bmcl.2018.10.005] |
Source(1):